We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Driving Drug Discovery Success With Synthetic Biology and NGS
Industry Insight

Technology Networks recently spoke with David Younger, PhD, Co-founder and CEO of A-Alpha Bio, to learn more about how the company has harnessed synthetic biology and next-generation sequencing techniques to measure millions of interactions between proteins in a single test tube. This enables the identification of potential drugs for the treatment of infectious diseases, including COVID-19.

Read More

Real-Time Wastewater Monitoring Enables Rapid COVID-19 Outbreak Detection
Industry Insight

We spoke to Ari Goldfarb, CEO of Kando, about how their wastewater monitoring technology works and how it is being applied to the current monitoring efforts in the COVID-19 pandemic.

Read More

Blood Test Detects Over 50 Different Cancers With a 0.7% False-Positive Rate
Industry Insight

Earlier this year, researchers reported in Annals of Oncology that they had developed a blood test that was able to detect, with 99.3% specificity, more than 50 types of cancer and identify exactly where in the body the cancer had originated – in some cases before any symptoms of the disease had manifested. We spoke to the study’s corresponding author, Michael V. Seiden MD PhD, to learn more.

Read More

From Genome Engineering to COVID-19 Diagnostic Testing at IGI
Industry Insight

The Innovative Genomics Institute (IGI) has launched an impressive COVID-19 diagnostic testing laboratory at UC Berkeley. Technology Networks spoke with Professor Jennifer Doudna, Executive Director at IGI and Professor of Molecular and Cell Biology and Chemistry at the University of California, Berkeley, to learn exactly how this ambitious effort has been achieved.

Read More

13 COVID-19 Vaccines Are in Human Clinical Trials – What Are They?
Industry Insight

The World Health Organization recognizes that, as of June 22, there are over 140 vaccines against COVID-19 in various stages of development. 13 of those candidates are now in human clinical trials. In this insights piece, we explore what those candidates are, and who is developing them.

Read More

Metagenomics As a Tool To Diagnose and Understand COVID-19
Industry Insight

To learn how clinical metagenomics can be used as a tool to diagnose and understand pathogens such as SARS-CoV-2, Technology Networks recently spoke with Robert Schlaberg, co-founder and CMO of IDbyDNA.

Read More

Improving Gene Editing by Promoting Error-free Repair of CRISPR/Cas9-cut DNA
Industry Insight

With the first clinical trial of CRISPR gene editing in progress and the controversy of the first gene-edited babies continuing to spark discussion, it is more important than ever to better understand not only the benefits but also the risks of CRISPR-based therapies.

Read More

More Sensitive COVID-19 Testing Using Droplet Digital PCR
Industry Insight

We recently spoke with experts at Bio-Rad to learn more about the reasons for, and significance of, false negative test results, and how the use of a more sensitive test could help to reduce this problem.

Read More

A "Plant Paternity Test" To Limit Global Food Wastage
Industry Insight

Dr Wirulda Pootakham is a Thai entrepreneur who has created a "plant paternity test" – HybridSure – which enables seed production companies to assess the genetic purity of hybrid seeds faster than traditional methods.

Read More

Developing the World's First Single Molecule Protein Sequencer
Industry Insight

Jagannath Swaminathan is the co-founder of Erisyon and a researcher at the Marcotte Lab at the University of Texas Austin. In this interview, we discuss the concept of next-generation protein sequencing, clinical proteomics and the critical role of protein sequencing in the fight against COVID-19.

Read More

 
Advertisement